Early-stage beta
· Errors & gaps may exist · Expanding: US · Nordics · EU
← All companies
/
Top lists
/
Chemometec
Chemometec
2022–2025 · Healthcare
2026-08-11
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2022
2023
2024
2025
Revenue
427
442
407
496
Operating profit (EBIT)
203
231
169
237
Net income attributable to shareholders
159
179
136
186
EBIT margin
47,5%
52,1%
41,5%
47,7%
Operating cash flow
177
154
129
207
Free cash flow
121
113
85
143
Cash
209
317
296
342
0
200
400
600
0,0%
20,0%
40,0%
60,0%
2022
2023
2024
2025
427
442
407
496
203
231
169
237